SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-041160
Filing Date
2024-03-29
Accepted
2024-03-29 16:30:26
Documents
13
Period of Report
2024-03-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm249556d2_8k.htm   iXBRL 8-K 28729
  Complete submission text file 0001104659-24-041160.txt   200146

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA uthr-20240329.xsd EX-101.SCH 3012
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE uthr-20240329_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE uthr-20240329_pre.xml EX-101.PRE 22357
16 EXTRACTED XBRL INSTANCE DOCUMENT tm249556d2_8k_htm.xml XML 3508
Mailing Address 1000 SPRING ST SILVER SPRING MD 20910
Business Address 1000 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26301 | Film No.: 24804437
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)